About ATTD Education and its Supporters

The International Conference on Advanced Technologies and Treatments for Diabetes (ATTD) has become the premier international forum to present and discuss innovative technologies and comprehensive overview of the latest research developments in this field. The purpose of the meeting is to discuss and disseminate information on the latest technologies and treatments for diabetes.


 

ATTD Education

The world of diabetes treatment is evolving at a dynamic pace that requires harmonization with research, technical advances and devices innovations.

Over the last 10 years, the International Conference on Advanced Technologies and Treatments for Diabetes ( ATTD) has become the premier international forum to present and discuss innovative technologies and comprehensive overview of the latest research developments in this field.The ATTD meetings started in 2008 in Prague with approx. 740 participants and grew to more than 2900 participants to date.

The 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020), took place on 19 - 22 February 2020 in Madrid. The meeting showcased the latest, world-changing, innovations and research in Technologies & Treatments for Diabetes. To access materials that presented at this conference, click here.

The ATTD brings together clinicians, such as diabetologists, endocrinologists, pediatricians and family medicine practitioners, scientists, engineers, start-up companies, investors, medical corporations, regulators and payers from all over the world who take active part in the conference, with lectures, workshops and posters and oral presentations, in order to share knowledge and develop collaborations.

Main topics of the ATTD meetings are: closed-loop systems and artificial pancreas, clinical decision support systems/advisors, insulin pumps, glucose sensors (invasive and non-invasive), implantable pumps and sensors, new insulins and new insulin delivery systems, devices focused on diabetes prevention, informatics in the service of medicine; telemedicine, software and other advanced medical technologies to be used in hospitals; new technologies for treating obesity, diabesity - methods to control or prevent diabetes in obese people, glycemic control in the hospital and blood glucose monitoring in intensive care units.

ATTD launched this new Education Portal to supplement its' live event, and plans to develop future learning activities such as eLearning courses, as well as including ePosters, webcasts and abstracts from the ATTD conference.


ATTD Education Portal 2020 Supporters

The ATTD Education Portal has been supported by an educational grant from the following supporters:  

ASTRAZENECA | MEDTRONIC | SANOFI


this image says Thank you to the ATTD 2020 Supporters - it includes logos for AstraZeneca , Medtronic , and Sanofi